Abstract
1 Tienilic acid, a diuretic with potent uricosuric properties, has been compared with conventional diuretic therapy, mainly thiazide, in a parallel group (random allocation) multicentre study in hyperuricaemic hypertensives (n = 96). 2 The study was designed to last 1 year but tienilic acid was withdrawn for suspected hepatotoxicity before the study was complete. Mean follow-up was 8.5 (range 1-12) months and the mean daily dose of tienilic acid was 278 (range 125-500 mg). 3 Blood pressure levels on tienilic acid and on conventional diuretics were similar. 4 Serum potassium and sodium levels were also similar in the two groups, but serum urea and creatinine rose somewhat more in the tienilic acid group. 5 Serum uric acid fell dramatically in the patients on tienilic acid from 0.56 to 0.32 mmol/l, but did not alter significantly in the control group. 6 There were no problems with renal failure or urate deposition probably because patients were instructed to drink plenty of fluid when tienilic acid was started, because initial dose was low and because all previous diuretics were stopped for 3 days before tienilic acid was started. 7 Mean liver function indices did not rise in either group. Mild elevation in liver enzymes occurred in one control patient and one patient on tienilic acid; the latter drug was stopped and the values returned to normal. 8 The general incidence of side-effects was low. 9 Our impression was that tienilic acid was a useful drug. Whether it could have been used safely with monitoring of liver function will not now be known.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barclay W. R. Ticrynafen's withdrawal from the market. JAMA. 1980 Feb 22;243(8):771–771. [PubMed] [Google Scholar]
- Bauer J. H., Brooks C. S. Comparative effects of ticrynafen and hydrochlorothiazide on blood pressure, renal function, serum uric acid and electrolytes, and body fluid spaces in hypertensive man. Nephron. 1979;23 (Suppl 1):57–63. doi: 10.1159/000181670. [DOI] [PubMed] [Google Scholar]
- Beevers D. G., Walker J. M. Total ban on tienilic acid. Lancet. 1980 Jun 28;1(8183):1417–1417. doi: 10.1016/s0140-6736(80)92680-x. [DOI] [PubMed] [Google Scholar]
- Beg M. A., Zuccarello W., Donikian M. A., Ragland R., Ziv D. S. Renal function during ticrynafen therapy. Nephron. 1979;23 (Suppl 1):64–66. doi: 10.1159/000181671. [DOI] [PubMed] [Google Scholar]
- Bennett W. M., Van Zee P. E., Hutchings R. Acute renal failure from ticrynafen. N Engl J Med. 1979 Nov 22;301(21):1179–1180. doi: 10.1056/NEJM197911223012112. [DOI] [PubMed] [Google Scholar]
- Bolli P., Simpson F. O., Waal-Manning H. J. Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients. Lancet. 1978 Sep 16;2(8090):595–598. doi: 10.1016/s0140-6736(78)92822-2. [DOI] [PubMed] [Google Scholar]
- Gillies A. H., Morgan T. O. A double-blind comparison of the effects of hydrochlorothiazide and tienylic acid (a diuretic with uricosuric properties) in hypertension. Br J Clin Pharmacol. 1978 Oct;6(4):357–362. doi: 10.1111/j.1365-2125.1978.tb00864.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang C. M., Chock D., del Greco F., Armstrong M., Kroc J., Quintanilla A. Antihypertensive and hemodynamic effects of ticrynafen compared with hydrochlorothiazide. Nephron. 1979;23 (Suppl 1):51–56. doi: 10.1159/000181669. [DOI] [PubMed] [Google Scholar]
- Jain A. K., Ryan J. R., McMahon F. G. Comparison of ticrynafen and probenecid in patients with elevated uric acid levels. Nephron. 1979;23 (Suppl 1):46–50. doi: 10.1159/000181668. [DOI] [PubMed] [Google Scholar]
- King R. S., Wichman B. A. Acute arthralgia (gout?) after tricrynafen. N Engl J Med. 1979 Nov 8;301(19):1065–1065. doi: 10.1056/NEJM197911083011916. [DOI] [PubMed] [Google Scholar]
- Lau K., Stote R. M., Goldberg M., Agus Z. S. Mechanisms of the uricosuric effect of the diuretic tienilic acid (Ticrynafen) in man. Clin Sci Mol Med. 1977 Oct;53(4):379–386. doi: 10.1042/cs0530379. [DOI] [PubMed] [Google Scholar]
- Lemieux G., Gougoux A., Vinay P., Kiss A., Baverel G. Metabolic effects in man of tienilic acid, a new diuretic with uricosuric properties. Nephron. 1978;20(1):54–64. doi: 10.1159/000184854. [DOI] [PubMed] [Google Scholar]
- McLain D. A., Garriga F. J., Kantor O. S. Adverse reactions associated with ticrynafen use. JAMA. 1980 Feb 22;243(8):763–764. [PubMed] [Google Scholar]
- Miller S. A., Vertes V. Ticrynafen and hydrochlorothiazide. A double-blind study of antihypertensive properties with an open crossover. JAMA. 1979 May 18;241(20):2174–2176. doi: 10.1001/jama.241.20.2174. [DOI] [PubMed] [Google Scholar]
- Okun R., Beg M. Ticrynafen and hydrochlorothiazide in hypertension. Clin Pharmacol Ther. 1978 Jun;23(6):703–711. doi: 10.1002/cpt1978236703. [DOI] [PubMed] [Google Scholar]
- Reese O. G., Jr, Steele T. H. Renal transport of urate during diuretic-induced hypouricemia. Am J Med. 1976 Jun;60(7):973–979. doi: 10.1016/0002-9343(76)90569-6. [DOI] [PubMed] [Google Scholar]
- Sawa H., Yamakawa H., Renjel L. E., Fernandes M. Acute renal failure during treatment with ticrynafen. JAMA. 1980 Feb 22;243(8):766–767. [PubMed] [Google Scholar]
- Selby T. Acute renal failure from ticrynafen. N Engl J Med. 1979 Nov 22;301(21):1180–1181. [PubMed] [Google Scholar]
- Simpson F. O., Waal-Manning H. J. Total ban on tienilic acid. Lancet. 1980 May 3;1(8175):978–979. doi: 10.1016/s0140-6736(80)91421-x. [DOI] [PubMed] [Google Scholar]
- Smith J. W., Clements P. Renal function during therapy in patients with congestive cardiac failure. Ticrynafen vs. hydrochlorothiazide. Nephron. 1979;23 (Suppl 1):41–45. doi: 10.1159/000181667. [DOI] [PubMed] [Google Scholar]
- Stote R. M., Dubb J. W., Familiar R. G., Alexander F. Ticrynafen, a uricosuric antihypertensive diuretic. Clin Pharmacol Ther. 1978 Apr;23(4):456–460. doi: 10.1002/cpt1978234456. [DOI] [PubMed] [Google Scholar]
- Waal-Manning H. J., Simpson F. O. One year follow-up of hyperuricaemic hypertensive patients treated with tienilic acid or a diuretic with or without uric acid-lowering drugs. Clin Sci (Lond) 1979 Dec;57 (Suppl 5):379s–382s. doi: 10.1042/cs057379s. [DOI] [PubMed] [Google Scholar]
- Wood A. J., Bolli P., Waal-Manning H. J., Simpson F. O. Ticrynafen: kinetics, protein binding, and effects on serum and urinary uric acid. Clin Pharmacol Ther. 1978 Jun;23(6):697–702. doi: 10.1002/cpt1978236697. [DOI] [PubMed] [Google Scholar]
